Techprecision Corp

This non-binding management proposal asks stockholders to approve, on an advisory basis, the compensation paid to the Company’s Named Executive Officers as disclosed in the proxy statement. Management seeks the advisory approval to provide stockholders an opportunity to express their view on overall executive pay and to confirm alignment of pay practices with company performance and shareholder interests; the board previously determined to hold say-on-pay votes annually. The Board frames the proposal as a vote on the company’s compensation philosophy, policies and practices rather than any single element of pay, and it states that it will consider significant negative votes in assessing whether changes are necessary. The advisory nature means the vote is not binding, but a strong negative result could pressure the Compensation Committee to revise plan design, targets, or disclosure. The proposal sits amid pay practices that include base salary, potential annual cash bonuses, long-term equity incentives (restricted stock and options) with multi-year vesting, and employment agreements for the CEO and CFO; these elements are intended to promote retention and align executives’ interests with long-term shareholder value. There is no explicit minimum approval threshold beyond majority of votes cast, and broker non-votes and abstentions are not counted in the result. Management’s recommendation for a FOR vote is justified by the Board on the basis that the programs and disclosures were appropriate for fiscal 2026 and support recruiting, retention and alignment with performance. In evaluating the governance merits, a sophisticated analyst should weigh the non-binding nature of the vote, the company’s disclosure and pay-for-performance metrics (including the Pay vs. Performance table), the role of equity with multi-year vesting, and the Board’s stated commitment to consider stockholder feedback in the event of significant opposition.

This management proposal asks stockholders to approve an Amended and Restated version of the Company’s 2016 Equity Incentive Plan that increases the available share reserve for future awards by 750,000 shares and implements a range of technical and governance updates. Management and the Compensation Committee are seeking shareholder approval to ensure the company has sufficient equity to continue using stock-based compensation as a core element of recruiting, retention, and pay-for-performance alignment in a competitive defense and aerospace manufacturing labor market. Key plan governance changes include a fixed ten-year term, explicit director compensation caps tied to total cash and equity value, an express prohibition on repricing without shareholder approval, and limitations on dividend-equivalent payments before vesting — measures intended to mitigate dilution and protect shareholder interests. The proposal also removes some previously rigid per-participant limits to provide the Compensation Committee greater flexibility to design awards consistent with market practice and performance objectives, while preserving stockholder approval triggers for certain material changes. Management quantifies expected dilution — up to 1,110,635 shares on a fully-diluted basis, roughly 9.9% of outstanding shares as of the record date — which is material and should be weighed against the company’s retention needs and pipeline of grants. The Board’s recommendation for a FOR vote is grounded in the view that lacking additional share capacity would force the company to rely on cash compensation, increasing expenses and weakening alignment of management incentives with long-term shareholder value. A sophisticated assessment should consider the plan’s anti-repricing and clawback provisions, the stated director limits, the removal of some per-participant limits (which increases flexibility but could raise governance questions), the explicit ten-year sunset, and the company’s current outstanding awards and exercise prices. Overall, the proposal balances an increased share reserve with several governance protections, but investors should evaluate dilution impact versus retention benefits and the Compensation Committee’s future grant practices.